Aurinia Pharmaceuticals, Inc. (AUPH)
15.67
+0.14
(+0.90%)
USD |
NASDAQ |
Dec 10, 12:00
Aurinia Pharmaceuticals Total Assets (Quarterly): 527.53M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Halozyme Therapeutics, Inc. | 2.221B |
| Oncolytics Biotech, Inc. | 10.82M |
| Edesa Biotech, Inc. | 14.80M |
| Lexaria Bioscience Corp. | 4.175M |
| Xenon Pharmaceuticals, Inc. | 607.84M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 161.76M |
| Shareholders Equity (Quarterly) | 365.77M |
| Debt to Equity Ratio | 0.2138 |
| Current Ratio | 5.756 |
| Net Debt Paydown Yield | 0.11% |